All Specialities
Peritoneal Cancer
Dedicated peritoneal surface malignancy programme for pseudomyxoma, mesothelioma and carcinomatosis.
Overview
Peritoneal surface malignancy is no longer terminal by default. Cytoreductive surgery combined with HIPEC delivers long-term survival in carefully selected patients.
Our approach
- Peritoneal Cancer Index scoring and patient selection
- Multi-visceral cytoreduction and peritonectomy
- HIPEC in the same operative sitting
- Structured critical-care and nutrition pathway
What to expect
- Complete cytoreduction
- Primary objective
- Programme volume
- High-volume centre
- Follow-up
- Lifelong surveillance
Every plan is individualised after imaging and pathology review in a multidisciplinary tumour board.
FAQ
The questions patients actually ask.
Book Appointment
Bring your reports. Leave with a plan.
Consultations are 45 minutes. Second opinions on existing reports are welcome, in person or by teleconsultation.
Availability
Mon
10:00 – 14:00
Tue
10:00 – 13:00
Wed
Operating day
Thu
10:00 – 14:00
Fri
10:00 – 13:00
Sat
10:00 – 12:00